Navidea Biopharmaceuticals | Investor Presentation Deck | 18 slides · page 12 of 18
The slide outlines key regulatory steps including FDA meetings, Phase 3 status, and clinical trial enrollment targets.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 3/3
callout 1/1 list 1/1 title 1/1
Components 3
primary bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.